Loomis Sayles & CO L P Regeneron Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

$70.3 Billion
Q1 2024

A detailed history of Loomis Sayles & CO L P transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Loomis Sayles & CO L P holds 1,207,195 shares of REGN stock, worth $1.25 Billion. This represents 1.65% of its overall portfolio holdings.

Number of Shares

1,207,195

Previous 1,219,067 0.97%

Holding current value

$1.25 Billion

Previous $1.07 Billion 8.52%

% of portfolio

1.65%

Previous 1.64%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $10.7 Million - $11.8 Million	-11,872 Reduced 0.97%	1,207,195 $1.16 Billion
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $10.7 Million - $12.2 Million	-13,812 Reduced 1.12%	1,219,067 $1.07 Billion
Q3 2023 Nov 09, 2023	SELL	$692.45 - $844.37 $30.9 Million - $37.7 Million	-44,605 Reduced 3.49%	1,232,879 $1.01 Billion
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $24.4 Million - $29 Million	-34,923 Reduced 2.66%	1,277,484 $918 Million
Q1 2023 May 11, 2023	SELL	$680.49 - $826.97 $17.2 Million - $20.9 Million	-25,274 Reduced 1.89%	1,312,407 $1.08 Billion

Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $267 Million - $290 Million	-378,936 Reduced 22.07%	1,337,681 $965 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $27.6 Million - $34.9 Million	-48,171 Reduced 2.73%	1,716,617 $1.18 Billion
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $430 Million - $579 Million	-783,259 Reduced 30.74%	1,764,788 $1.04 Billion
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $48.3 Million - $56.6 Million	-81,104 Reduced 3.08%	2,548,047 $1.78 Billion
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $69.3 Million - $85.6 Million	-127,584 Reduced 4.63%	2,629,151 $1.66 Billion
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $1.44 Million - $1.71 Million	2,511 Added 0.09%	2,756,735 $1.67 Billion
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $57.7 Million - $68.2 Million	-122,144 Reduced 4.25%	2,754,224 $1.54 Billion
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $39.4 Million - $48.4 Million	-88,215 Reduced 2.98%	2,876,368 $1.36 Billion
Q4 2020 Feb 12, 2021	SELL	$478.3 - $607.98 $101 Million - $129 Million	-211,415 Reduced 6.66%	2,964,583 $1.43 Billion
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $45.6 Million - $55.1 Million	-83,700 Reduced 2.57%	3,175,998 $1.78 Billion
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $115 Million - $150 Million	-233,115 Reduced 6.67%	3,259,698 $2.03 Billion
Q1 2020 May 15, 2020	SELL	$336.18 - $494.43 $67.2 Million - $98.8 Million	-199,862 Reduced 5.41%	3,492,813 $1.71 Billion
Q4 2019 Feb 14, 2020	BUY	$274.13 - $376.51 $27.7 Million - $38 Million	100,878 Added 2.81%	3,692,675 $1.39 Billion
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $85.2 Million - $99.2 Million	311,476 Added 9.5%	3,591,797 $996 Million
Q2 2019 Aug 14, 2019	BUY	$299.6 - $414.82 $31 Million - $43 Million	103,634 Added 3.26%	3,280,321 $1.03 Billion
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $5.78 Million - $6.83 Million	15,540 Added 0.49%	3,176,687 $1.3 Billion
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $62.2 Million - $74.6 Million	-185,133 Reduced 5.53%	3,161,147 $1.18 Billion
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $14.4 Million - $16.8 Million	41,138 Added 1.24%	3,346,280 $1.35 Billion
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $138 Million - $167 Million	485,387 Added 17.21%	3,305,142 $1.14 Billion
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $227 Million - $283 Million	718,144 Added 34.17%	2,819,755 $971 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $83 Million - $109 Million	231,560 Added 12.38%	2,101,611 $790 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $20.6 Million - $24.1 Million	47,755 Added 2.62%	1,870,051 $836 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,822,296	1,822,296 $895 Million

Others Institutions Holding REGN

# of Institutions

1,426

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $111B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Regeneron Pharmaceuticals, Inc. Transaction History